Cabaniog, Norvile O.
HRN: 00-75-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2024
MUPIROCIN 2%, 15G (TUBE)
11/17/2024
11/24/2024
TOP
2%
BID
SKIN RASHES
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes